3 days ago · View Intellia Therapeutics, Inc NTLA investment & stock information. Get the latest Intellia Therapeutics, Inc NTLA detailed stock quotes, stock data, Real-Time ECN, …View Intellia Therapeutics (NTLA) stock price, news, historical charts, analyst ratings, financial information and quotes on Moomoo.Jan 5, 2024 · Intellia Therapeutics, Inc. Stock price Berne S.E. Equities 38I US45826J1051 ... Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course ...Feb 14, 2024 · View Intellia Therapeutics, Inc. NTLA stock quote prices, financial information, real-time forecasts, and company news from CNN.Trefis Estimates Intellia Therapeutics Valuation At $26.00 Per Share · Valuation Derived From: [1] Price To Sales Ratio (P/S) Based Estimate · [1] Price To Sales ...5 May 2016 ... Intellia's common stock is expected to begin trading on the NASDAQ Global Market under the ticker symbol "NTLA" on May 6, 2016 . Credit Suisse , ....Intellia Therapeutics Inc stock price live 27.74, this page displays NASDAQ NTLA stock exchange data. View the NTLA premarket stock price ahead of the market session or assess the after hours quote.Track Intellia Therapeutics Inc (NTLA) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Before you buy stock in Intellia Therapeutics, consider this: ... Last Price Change % Change; NTLA. Intellia Therapeutics, Inc. 28.54 +0.26 +0.92%: TRENDING. 1. Cisco could have a long road to ...Dec 3, 2021 · Intellia Therapeutics, Inc. Common Stock (NTLA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.RBC Cuts Price Target on Intellia Therapeutics to $70 From $80, Keeps Outperform, Speculative Risk Nov. 10: MT ... Stock Intellia Therapeutics, Inc. - Nasdaq . News Intellia Therapeutics, Inc. Transcript : Intellia Therapeutics, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-09-2024 05 ...Summary Volume and Price by Trading Session for NTLA ; Prev Close, 28.47, 27.47 ; Premarket VWAP, 28.06, 27.47 ; Open Cross, 27.59, 27.47 ; Regular Hours VWAP ...The Intellia Therapeutics Inc ( NTLA) stock price forecast for the next 12 months is generally positive, with an average analyst price target of $35.09, representing a +29.23% increase from the current price of $27.15. The highest analyst price target is $39.38, and the lowest is $30.80. Based on our technical indicators, the current sentiment ...Wall Street Stock Market & Finance report, prediction for the future: You'll find the Intellia Therapeutics share forecasts, stock quote and buy / sell signals below. According to present data Intellia Therapeutics's NTLA shares and potentially its market environment have been in bearish cycle last 12 months (if exists). 12 hours ago · Intellia Therapeutics price target lowered to $64 from $78 at Guggenheim Intellia Therapeutics price target raised to $73 from $72 at Canaccord Intellia Therapeutics reports Q4 EPS ($1.46 ... NTLA - Intellia Therapeutics, Inc. Stock - Share Price, Short Interest, Short Squeeze, Borrow Rates (NasdaqGM)The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Intellia Therapeutics wasn’t one of them. The 10 stocks that ...The stock price of Intellia Therapeutics, a biotechnology company developing treatments using a CRISPR gene-editing system, has seen a stellar 70% rise in just two trading days, after the company ...The Intellia Therapeutics stock forecast for tomorrow is $ 27.15, which would represent a -2.12% loss compared to the current price. In the next week, the price of NTLA is expected to decrease by -2.51% and hit $ 27.04.. As far as the long-term Intellia Therapeutics stock forecast is concerned, here’s what our predictions are currently …4 days ago · Intellia Therapeutics, Inc. (NTLA) Stock Price | Stock Quote Nasdaq - MarketScreener INTELLIA THERAPEUTICS, INC. PDF Report Equities NTLA …On average, Wall Street analysts predict. that Intellia Therapeutics's share price could reach $77.86 by Nov 13, 2024. The average Intellia Therapeutics stock price prediction forecasts a potential upside of 162.94% from the current NTLA share price of $29.61 .Intellia Therapeutics Inc’s Stock Price Change Based on Its Q3 Earnings Report. The stock market is considered to always be “forward-looking,” which means share prices are established based on the expectations that prospective investors have for the future earnings power of the company. In fact, expectations play a key role in determining ...5 days ago · Intellia Therapeutics Inc Stock Add to Watchlist Overview Forecast Earnings Dividend Ownership $27.15 -0.59 (-2.13%) Updated Feb 20, 2024 1W + 2.65% 1M + …Research Intellia Therapeutics' (Nasdaq:NTLA) stock key valuation metrics while comparing it with its industry peers & market side by side. ... The above table shows the analyst NTLA forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current ...NTLA | Complete Intellia Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Jan 5, 2024 · Intellia Therapeutics, Inc. Stock price Berne S.E. Equities 38I US45826J1051 ... What are the best stocks to buy? Learn how you can make that decision for yourself at InvestorPlace. With the help of experienced financial advisors, InvestorPlace can give you the...Intellia Therapeutics Inc Stock Price History. Intellia Therapeutics Inc’s price is currently up 7.53% so far this month. During the month of December, Intellia Therapeutics Inc’s stock price has reached a high of $33.60 and a low of $26.95. Over the last year, Intellia Therapeutics Inc has hit prices as high as $47.48 and as low as $22.67 ...On Friday, Canaccord Genuity maintained a Buy rating on Intellia Therapeutics (NASDAQ: NTLA ) and slightly increased the price target to $73 from $72.The adjustment follows Intellia's fourth-quarter earnings report, which aligned with expectations set by an early January pre-announcement.Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 …4 days ago · Intellia Therapeutics stock gains on CRISPR treatment results. Intellia Therapeutics Inc. NTLA, -0.28% shares gained 6.4% premarket on Monday after the clinical stage genome-editing company announced new data from a trial of an investigational CRISPR-based therap... Other symbols: CRSP. 2 days ago · On Friday, Canaccord Genuity maintained a Buy rating on Intellia Therapeutics (NASDAQ:NTLA) and slightly increased the price target to $73 from $72. The adjustment follows Intellia's fourth ... r/IntelliaTherapeutics: Unofficial - Intellia Therapeutics Stock Message Board on Reddit. CRISPR technology and stock prices discussion.Intellia Therapeutics, Inc. price-consensus-chart | Intellia Therapeutics, Inc. Quote. In fact, over the past month, current quarter estimates have narrowed from a loss of $1.51 per share to a ...Wall Street Stock Market & Finance report, prediction for the future: You'll find the Intellia Therapeutics share forecasts, stock quote and buy / sell signals below. According to present data Intellia Therapeutics's NTLA shares and potentially its market environment have been in bearish cycle last 12 months (if exists).Wall Street analysts are quite bullish about Intellia Therapeutics (NTLA-2.84%) stock. On average, they're estimating that it'll rise by around 157% within the next 12 months. In the context of ...If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up t...Open a brokerage account and deposit funds in it to purchase stock in a company, explains the Wall Street Journal. Companies such as Charles Schwab, E-Trade, and Ameritrade provide...Get Intellia Therapeutics Inc (NTLA.A) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsIntellia Therapeutics, Inc. Common Stock (NTLA) After-Hours Stock Quotes ... You'll now be able to see real-time price and activity for your symbols on the My Quotes of Nasdaq.com.4 days ago · Feb. 15. MT. Morgan Stanley Adjusts Intellia Therapeutics' Price Target to $85 From $90, Keeps Overweight Rating. Nov. 13. MT. Oppenheimer Slashes Price Target on Intellia Therapeutics to $70 From $80, Maintains Outperform Rating. Nov. 13. MT. Goldman Sachs Adjusts Price Target on Intellia Therapeutics to $136 From $157, Maintains Buy Rating. May 24, 2002 · Real-time Price Updates for Intellia Thera CS (NTLA-Q), along with buy or sell indicators, analysis, charts, historical performance, news and more Intellia Therapeutics (NTLA) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more.Wall Street Stock Market & Finance report, prediction for the future: You'll find the Intellia Therapeutics share forecasts, stock quote and buy / sell signals below. According to present data Intellia Therapeutics's NTLA shares and potentially its market environment have been in bearish cycle last 12 months (if exists).Fiscal Q3 2023 ended 9/30/23. Reported on 11/9/23. Get the latest Intellia Therapeutics Inc (NTLA) real-time quote, historical performance, charts, and other financial information to help you... 02/22/2024. Intellia Therapeutics stock price stood at $27.18. According to the latest long-term forecast, Intellia Therapeutics price will hit $30 by the end of 2024 and then $40 by the middle of 2025. Intellia Therapeutics will rise to $45 within the year of 2026, $55 in 2027, $65 in 2028, $75 in 2029, $85 in 2030, $90 in 2032, $95 in 2033 and $100 …Dec 31, 2016 · Summary of all time highs, changes and price drops for Intellia Therapeutics; Historical stock prices; Current Share Price: US$26.10: 52 Week High: US$47.48: 52 Week Low: Intellia Therapeutics, Inc. Common Stock (NTLA) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. Intellia Therapeutics (NASDAQ: NTLA) $26.45. (-10.7%) -$3.16. Price as of February 13, 2024, 4:00 p.m. ET. You’re reading a free stock page from The Motley Fool’s Premium …Intellia Therapeutics Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time NTLA stock price.Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins an...24 Nov 2023 ... Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing ...Intellia Therapeutics Inc’s Stock Price as of Market Close. As of November 22, 2023, 4:00 PM, CST, Intellia Therapeutics Inc’s stock price was $30.26. Intellia Therapeutics Inc is up 6.32% from its previous closing price of $28.46. During the last market session, Intellia Therapeutics Inc’s stock traded between $28.43 and $29.84.Stock Price Forecast The 24 analysts offering 12-month price forecasts for Intellia Therapeutics Inc have a median target of 71.50, with a high estimate of 145.00 and a low estimate of 29.00. The median estimate represents a +183.06% increase from the …On Friday, Goldman Sachs adjusted its stance on Intellia Therapeutics (NASDAQ:NTLA), downgrading the stock from Buy to Neutral and setting a new price target of $32.00. The change follows Intellia ...Feb 17, 2024 · The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Intellia Therapeutics wasn’t one of them. The 10 stocks that ... Intellia Therapeutics Inc stock price (NTLA) NASDAQ: NTLA. ... Intellia Therapeutics Inc stock performance at a glance. Check Intellia Therapeutics Inc’s past financial performance, like revenue or net income, plus the top …Real time Intellia Therapeutics (NTLA) stock price quote, stock graph, news & analysis. Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest...Intellia's (NTLA) in-vivo CRISPR-based gene-edited therapy candidate NTLA-2001 holds potential. ... Free Stock Analysis Report. Intellia Therapeutics, Inc. (NTLA) : Free Stock Analysis Report ...Real-time Price Updates for Intellia Thera CS (NTLA-Q), along with buy or sell indicators, analysis, charts, historical performance, news and moreJan 19, 2024 · Intellia Therapeutics, Inc. (38I.) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Intellia Therapeutics, Inc. | Börse Stuttgart ... On Friday, Canaccord Genuity maintained a Buy rating on Intellia Therapeutics (NASDAQ: NTLA) and slightly increased the price target to $73 from $72.The adjustment follows Intellia's fourth-quarter earnings report, which aligned with expectations set by an early January pre-announcement.Feb 12, 2024 · Get Intellia Therapeutics Inc (NTLA.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments View a financial market summary for NTLA including stock price quote, trading volume, volatility, options volume, statistics, and other important company data related to NTLA (Intellia Therapeutics) stock. ... What is Intellia Therapeutics stock price doing today? As of February 23, 2024, NTLA stock price declined to $26.10 with …Intellia Therapeutics stock opened at $26.10 on Friday. The stock’s 50-day moving average is $27.92 and its 200-day moving average is $30.40. The company has a market cap of $2.34 billion, a ...Trefis Estimates Intellia Therapeutics Valuation At $26.00 Per Share · Valuation Derived From: [1] Price To Sales Ratio (P/S) Based Estimate · [1] Price To Sales ...3 days ago · Based on short-term price targets offered by 23 analysts, the average price target for Intellia Therapeutics, Inc. comes to $77.61. The forecasts range from a low of $29.00 to a high of $145.00. Intellia Therapeutics, Inc. Common Stock (NTLA) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets. Find the latest Intellia Therapeutics, Inc. (NTLA) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. 02/22/2024. Intellia Therapeutics stock price stood at $27.18. According to the latest long-term forecast, Intellia Therapeutics price will hit $30 by the end of 2024 and then $40 by the middle of 2025. Intellia Therapeutics will rise to $45 within the year of 2026, $55 in 2027, $65 in 2028, $75 in 2029, $85 in 2030, $90 in 2032, $95 in 2033 and $100 …Intellia Therapeutics Inc stock price (NTLA) NASDAQ: NTLA. ... Intellia Therapeutics Inc stock performance at a glance. Check Intellia Therapeutics Inc’s past financial performance, like revenue or net income, plus the top …This stock has a credible chance of climbing, if not soaring. Analysts are almost certainly banking on the occurrence of several catalysts that will be necessary for Intellia to meet their price ...Intellia Therapeutics Inc (0JBU.): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Intellia Therapeutics Inc | CINNOBER BOAT: 0JBU ...Establishing ownership of stock depends on how the stock was purchased, according to the Securities and Exchange Commission. A brokerage firm may have purchased the stock or it may...These 4 analysts have an average price target of $80.75 versus the current price of Intellia Therapeutics at $23.64, implying upside. Below is a summary of how these 4 analysts rated Intellia ...On Friday, Canaccord Genuity maintained a Buy rating on Intellia Therapeutics (NASDAQ: NTLA ) and slightly increased the price target to $73 from $72.The adjustment follows Intellia's fourth-quarter earnings report, which aligned with expectations set by an early January pre-announcement.Intellia Therapeutics Inc. $26.88. NTLA 0.99%. Beam Therapeutics Inc. $31.76. ... A valuation method that multiplies the price of a company's stock by the total number of outstanding shares.The stock price of Intellia Therapeutics, a biotechnology company developing treatments using a CRISPR gene-editing system, has seen a significant 31% fall in a month while it is down 34% over the ...NasdaqGM - NasdaqGM Real Time Price. Currency in USD. Follow. Visitors trend 2W 10W 9M. 27.15-0.59 (-2.13%) At close: 04:00PM EST. ... Intellia Therapeutics, Inc., a genome editing company ...Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest...The average price target for Intellia Therapeutics is $72.29. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $95.00 ,the lowest forecast is $49.00. The average price target represents 173.31% Increase from the current price of $26.45.On average, Wall Street analysts predict. that Intellia Therapeutics's share price could reach $77.86 by Nov 13, 2024. The average Intellia Therapeutics stock price prediction forecasts a potential upside of 162.94% from the current NTLA share price of $29.61 .Intellia Therapeutics, Inc. Common Stock (NTLA) Real-time Stock Quotes ... You'll now be able to see real-time price and activity for your symbols on the My Quotes of Nasdaq.com.Wall Street Stock Market & Finance report, prediction for the future: You'll find the Intellia Therapeutics share forecasts, stock quote and buy / sell signals below. According to present data Intellia Therapeutics's NTLA shares and potentially its market environment have been in bearish cycle last 12 months (if exists).NTLA Intellia Therapeutics Inc. BPC Chart Overview 03/28/22 Intellia Therapeutics Inc. NASDAQ: NTLA Chart Overview 03/28/22 Intellia is trading in a 9-month downward channel pullback, closing the gap created by the release of Phase 1 data of NTLA-2001 to treat ATTR. The release caused a bull pennant that led to a reversal into a downward channel. Find the latest Intellia Therapeutics, Inc. (NTLA) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. Intellia stock price, tua concussion, netflix to download movies
30 Jan 2024 ... Intellia Therapeutics Inc is down 6.07% from its previous closing price of $26.18. During the last market session, Intellia Therapeutics Inc's .... Intellia stock price
big bad breakfast near meStock analysis for Intellia Therapeutics Inc (NTLA:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Price Target. Based on short-term price targets offered by 23 analysts, the average price target for Intellia Therapeutics, Inc. comes to $77.61. The forecasts range from a low of $29.00 to a high ...Summary Volume and Price by Trading Session for NTLA ; Prev Close, 28.47, 27.47 ; Premarket VWAP, 28.06, 27.47 ; Open Cross, 27.59, 27.47 ; Regular Hours VWAP ...Stock Price Forecast The 24 analysts offering 12-month price forecasts for Intellia Therapeutics Inc have a median target of 71.50, with a high estimate of 145.00 and a low estimate of 29.00. The median estimate represents a +183.06% increase from the …NTLA Intellia Therapeutics · High. 27.900 · Low. 26.010 · Volume. 922.77K · Open. 26.340 · Pre Close. 26.070 · Turnover. 24.99M · T...Overview News Intellia Therapeutics Inc. No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-5.35 Market Cap $2.55 B Shares Outstanding 88.49 M Public... 4 days ago · Intellia Therapeutics, Inc. (NASDAQ:NTLA) is a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies. The …Intellia Therapeutics Inc Stock Price History. Intellia Therapeutics Inc’s price is currently up 18.28% so far this month. During the month of November, Intellia Therapeutics Inc’s stock price has reached a high of $32.39 and a low of $22.67. Over the last year, Intellia Therapeutics Inc has hit prices as high as $51.94 and as low as $22.67 ...r/IntelliaTherapeutics: Unofficial - Intellia Therapeutics Stock Message Board on Reddit. CRISPR technology and stock prices discussion.Nasdaq provides Price/Earnings Ratio (or PE Ratio) and PEG ratio for stock evaluation. Financial analysts and individual investors use PE Ratio and PEG ratios to determine the financial ...This stock has a credible chance of climbing, if not soaring. Analysts are almost certainly banking on the occurrence of several catalysts that will be necessary for Intellia to meet their price ...Stock Price Forecast The 24 analysts offering 12-month price forecasts for Intellia Therapeutics Inc have a median target of 71.50, with a high estimate of 145.00 and a low estimate of 29.00. The median estimate represents a +183.06% increase from the …In 4 weeks Intellia Therapeutics stock prediction on Friday, March, 22: 27.95 dollars, maximum 30.19, minimum 25.71. Intellia Therapeutics stock price forecast ...Intellia Therapeutics stock price forecast* for tomorrow, and next weeks based on the last 30 days [60% OFF VIP SALE] Portfolio is UP +117% in 2023 - Try Now Risk-Free - Money-back guarantee! NTLA forecast for the upcoming days Date Price Min Price Max Price; 2024-02-26: Price: 26.742: Min: 25.357: Max: ...Intellia Therapeutics Inc’s Stock Price as of Market Close. As of November 20, 2023, 4:00 PM, CST, Intellia Therapeutics Inc’s stock price was $30.28. Intellia Therapeutics Inc is up 7.68% from its previous closing price of $28.12. During the last market session, Intellia Therapeutics Inc’s stock traded between $26.18 and $28.17.Intellia Therapeutics, Inc. Appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of ...With Intellia Therapeutics stock trading at $25.09 per share, the total value of Intellia Therapeutics stock (market capitalization) is $2.25B. Intellia Therapeutics stock was originally listed at a price of $22.10 in May 6, 2016. If you had invested in Intellia Therapeutics stock at $22.10, your return over the last 7 years would have been 13. ...NTLA | Complete Intellia Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. A company's cash runway is calculated by dividing its cash hoard by its cash burn. In September 2023, Intellia Therapeutics had US$855m in cash, and was debt-free. In the last year, its cash burn ...r/IntelliaTherapeutics: Unofficial - Intellia Therapeutics Stock Message Board on Reddit. CRISPR technology and stock prices discussion.Jan 21, 2024 · The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Intellia Therapeutics wasn't one of them. The 10 stocks that ... NTLA Price Action: Intellia shares were up 7.2% at $25.52 at the time of writing, per ... This article Why Intellia Therapeutics Stock Is Surging Tuesday originally appeared on Benzinga.com.On Friday, Canaccord Genuity (TSX: CF) maintained a Buy rating on Intellia Therapeutics (NASDAQ: NTLA) and slightly increased the price target to $73 from $72.The adjustment follows Intellia's fourth-quarter earnings report, which aligned with expectations set by an early January pre-announcement.Intellia Therapeutics (NASDAQ: NTLA) $26.45. (-10.7%) -$3.16. Price as of February 13, 2024, 4:00 p.m. ET. You’re reading a free stock page from The Motley Fool’s Premium …Intellia Therapeutics Announces Publication of Positive Interim Phase 1 Data for NTLA-2002 in Patients with Hereditary Angioedema in the New England Journal of Medicine. Find the latest Intellia Therapeutics, Inc. (NTLA) stock quote, history, news and other vital information to help you with your stock trading and investing.In other words, there will be updates along the way and the share price will go up or down depending on the updates. In other words, one doesn't have to wait for a long time for price movement ...Better Growth Stock: Intellia Therapeutics vs. CRISPR Therapeutics. By Alex Carchidi – Jan 21, 2024 at 8:00AM ... Current Price. $27.18. Price as of February 22, 2024, 4:00 p.m. ET.Nasdaq provides Price/Earnings Ratio (or PE Ratio) and PEG ratio for stock evaluation. Financial analysts and individual investors use PE Ratio and PEG ratios to determine the financial ...Intellia’s stock has plunged 22.7% in the past year compared with the industry’s decline of 12.5%. Zacks Investment Research. Image Source: Zacks Investment Research. NTLA-2002, Intellia’s ...Overview News Intellia Therapeutics Inc. No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-5.35 Market Cap $2.55 B Shares Outstanding 88.49 M Public... NTLA | Complete Intellia Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.On Friday, Canaccord Genuity maintained a Buy rating on Intellia Therapeutics (NASDAQ: NTLA) and slightly increased the price target to $73 from $72.The adjustment follows Intellia's fourth-quarter earnings report, which aligned with expectations set by an early January pre-announcement.What are the best stocks to buy? Learn how you can make that decision for yourself at InvestorPlace. With the help of experienced financial advisors, InvestorPlace can give you the...Overview News Intellia Therapeutics Inc. No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-5.35 Market Cap $2.55 B Shares Outstanding 88.49 M Public... View live Intellia Therapeutics, Inc. chart to track its stock's price action. Find market predictions, NTLA financials and market news.Fiscal Q3 2023 ended 9/30/23. Reported on 11/9/23. Get the latest Intellia Therapeutics Inc (NTLA) real-time quote, historical performance, charts, and other financial information to help you... This price target is based on 19 analysts offering 12 month price targets for Intellia Therapeutics in the last 3 months. The average price target is $74.11, with a high forecast of $136.00 and a low forecast of $29.00. The average price target represents a 174.08% upside from the last price of $27.04.RBC Cuts Price Target on Intellia Therapeutics to $70 From $80, Keeps Outperform, Speculative Risk Nov. 10: MT ... Stock Intellia Therapeutics, Inc. - Nasdaq . News Intellia Therapeutics, Inc. Transcript : Intellia Therapeutics, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-09-2024 05 ...Feb 9, 2024 · MT. Wedbush Lowers Intellia Therapeutics' Price Target to $29 From $45, Maintains Neutral Rating. Nov. 10. MT. Intellia Therapeutics Shares Fall After Net Loss Narrows, but Revenue Falls in Q3. Nov. 09. MT. Transcript : Intellia Therapeutics, Inc., Q3 2023 Earnings Call, Nov 09, 2023. Earnings Date. Feb 22, 2024. Forward Dividend & Yield. N/A (N/A) Ex-Dividend Date. N/A. 1y Target Est. 75.13. Fair Value is the appropriate price for the shares of a company, based on its... Intellia Therapeutics Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time NTLA stock price.The average price target for Intellia Therapeutics is $72.29. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $95.00 ,the lowest forecast is $49.00. The average price target represents 173.31% Increase from the current price of $26.45.30 Jan 2024 ... Intellia Therapeutics Inc is down 6.07% from its previous closing price of $26.18. During the last market session, Intellia Therapeutics Inc's ...The Vanguard Group, Inc. is the second largest shareholder owning 9.2% of common stock, and BlackRock, Inc. holds about 9.1% of the company stock. Furthermore, CEO John Leonard is the owner of 0.9 ...1 Jan 2024 ... Key Insights · The projected fair value for Intellia Therapeutics is US$40.78 based on 2 Stage Free Cash Flow to Equity · Current share price of ....5 days ago · Intellia Therapeutics Inc Stock Add to Watchlist Overview Forecast Earnings Dividend Ownership $27.15 -0.59 (-2.13%) Updated Feb 20, 2024 1W + 2.65% 1M + …Are you tired of spending endless hours searching for high-quality stock photos only to discover that they come with a hefty price tag? Look no further. In this article, we will ex...Intellia’s stock has plunged 22.7% in the past year compared with the industry’s decline of 12.5%. Zacks Investment Research. Image Source: Zacks Investment Research. NTLA-2002, Intellia’s ...If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up t...Factors That Drove Intellia Therapeutics (NTLA) Stock Price Change Between 2021-End And Now: ; Factors Of Stock Price Change ; Price To Sales Ratio (P/S), 264.4 ...This stock has a credible chance of climbing, if not soaring. Analysts are almost certainly banking on the occurrence of several catalysts that will be necessary for Intellia to meet their price ...3 days ago · NTLA | Complete Intellia Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.NTLA | Complete Intellia Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Intellia Therapeutics Inc stock price (NTLA) NASDAQ: NTLA. ... Intellia Therapeutics Inc stock performance at a glance. Check Intellia Therapeutics Inc’s past financial performance, like revenue or net income, plus the top …Intellia Therapeutics Inc’s Stock Price Change Based on Its Q3 Earnings Report. The stock market is considered to always be “forward-looking,” which means share prices are established based on the expectations that prospective investors have for the future earnings power of the company. In fact, expectations play a key role in determining ...Intellia Contacts: Investors: Ian Karp Senior Vice President, Investor Relations and Corporate Communications ... and got the Nvidia logo tattooed on his shoulder when the stock price hit $100.On Friday, Canaccord Genuity maintained a Buy rating on Intellia Therapeutics (NASDAQ: NTLA ) and slightly increased the price target to $73 from $72.The adjustment follows Intellia's fourth-quarter earnings report, which aligned with expectations set by an early January pre-announcement.Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis. In depth view into NTLA (Intellia Therapeutics) stock including the latest price, news, dividend history, earnings information and …4 days ago · Intellia Therapeutics stock gains on CRISPR treatment results. Intellia Therapeutics Inc. NTLA, -0.28% shares gained 6.4% premarket on Monday after the clinical stage genome-editing company announced new data from a trial of an investigational CRISPR-based therap... Other symbols: CRSP. On Friday, Canaccord Genuity maintained a Buy rating on Intellia Therapeutics (NASDAQ: NTLA ) and slightly increased the price target to $73 from $72.The adjustment follows Intellia's fourth-quarter earnings report, which aligned with expectations set by an early January pre-announcement.Intellia Therapeutics Stock Earnings. The value each NTLA share was expected to gain vs. the value that each NTLA share actually gained. Intellia Therapeutics ( NTLA) reported Q3 2023 earnings per share (EPS) of -$1.38, beating estimates of -$1.50 by 7.99%. In the same quarter last year, Intellia Therapeutics 's earnings per share (EPS) was -$1.49.3 days ago · Intellia Therapeutics Inc. Watch NEW Set a price target alert Premarket Last Updated: Feb 21, 2024 6:22 a.m. EST Delayed quote $ 27.27 0.12 0.44% Before Hours Volume: 480 Advanced Charting... Summary Volume and Price by Trading Session for NTLA ; Prev Close, 28.47, 27.47 ; Premarket VWAP, 28.06, 27.47 ; Open Cross, 27.59, 27.47 ; Regular Hours VWAP ...As of the second quarter of 2023, Intellia has nearly $1 billion in cash, equivalents, and short-term investments. Its trailing-12-month operating expenses are $513 million. Therefore, to continue ...At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. 5 days ago · 6.9%. Market Average Movement. 4.9%. 10% most volatile stocks in GB Market. 11.1%. 10% least volatile stocks in GB Market. 2.5%. Stable Share Price: 0JBU has not had significant price volatility in the past 3 months. Volatility Over Time: 0JBU's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of UK stocks. Intellia Therapeutics (NTLA) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more.This stock has a credible chance of climbing, if not soaring. Analysts are almost certainly banking on the occurrence of several catalysts that will be necessary for Intellia to meet their price ...The No. 2 U.S. automaker's lowest-price 2023 model year Mach E version now has a suggested retail price of $39,895, down from $42,995. Other versions including the extended-range premium version .... Nebraska vs wisconsin, how to draw bluey